Research presented at the latest American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) found that the immunotherapy agent sipuleucel-T, Provenge, appears safe for use in early stage prostate cancer.
Tag Archives | prostate
Dr. Jianqing Lin, medical oncologist at Jefferson, talks about his Phase I clinical trial investigating Cabazitaxel in combination with radiation and hormone therapy for prostate cancer.
November 4, 2003. The date is deeply etched in James Eisenhardt’s memory. On that day eight years ago, Jim’s long journey as a cancer patient began. That day also happens to be his wife’s birthday. November 4 was when this South Jersey man went for a colonoscopy in an effort to learn what was making more »
The first line of defense against prostate cancer is to have your PSA levels checked. There are many factors that can influence your PSA, and the results can be confusing. Dr. Jaspreet Singh, a urologist at Jefferson, can help.